{
    "code": "01036161",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=01036161",
    "time": "2020-01-31 04:00:55",
    "許可證字號": "衛署藥製字第036161號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "113\/12\/31",
    "發證日期": "82\/02\/19",
    "許可證種類": "製　劑",
    "舊證字號": "01025734",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHY00103616109",
    "中文品名": "&quot;東洲&quot; 西華黴素乾粉注射劑１０００公絲（西華樂林）",
    "英文品名": "ORICEF INJECTION &quot;ORIENTAL&quot; (CEFAZOLIN)",
    "適應症": "葡萄球菌、鏈球菌、肺炎雙球菌、腦膜炎球菌及其他具有感受性細菌引起之感染症",
    "劑型": "270注射劑",
    "包裝": "1000公絲小瓶裝 100支以下盒裝",
    "": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "-->\r\n                    \r\n                        \r\n                            標籤、仿單及包裝加註": [
        ""
    ],
    "藥品類別": "05限由醫師使用",
    "藥品分類": "",
    "主製造廠": {
        "限制項目": "01國　產 09委託製造 1G依藥品審查準則第64條 不得製造",
        "申請商名稱": "6231147074  東洲化學製藥廠股份有限公司",
        "申請商地址": "新北市蘆洲區中山二路195巷12號1-2樓",
        "主製造廠": ""
    },
    "CCC號列": "30042000319 人用醫藥製劑，含頭孢子菌類抗生素者Medicaments, containing cephalosporins, for human use",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "0812309510",
            "成分名稱": "CEFAZOLIN (SODIUM)",
            "含量描述": "(POTENCY)",
            "含量": "1000.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "010361610001仿單-西華黴素1g-1050728-105-08-05.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01036161&Seq=004&Type=9"
        },
        {
            "title": "西華黴素1g-標籤-105-08-05.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01036161&Seq=005&Type=8"
        }
    ]
}